These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1974305)

  • 1. Receptor-mediated prednisolone pharmacodynamics in rats: model verification using a dose-sparing regimen.
    Nichols AI; Jusko WJ
    J Pharmacokinet Biopharm; 1990 Jun; 18(3):189-208. PubMed ID: 1974305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-mediated pharmacodynamics of prednisolone in the rat.
    Boudinot FD; D'Ambrosio R; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):469-93. PubMed ID: 2879901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second generation model for prednisolone pharmacodynamics in the rat.
    Nichols AI; Boudinot FD; Jusko WJ
    J Pharmacokinet Biopharm; 1989 Apr; 17(2):209-27. PubMed ID: 2571711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.
    Haughey DB; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Aug; 20(4):333-55. PubMed ID: 1362219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the hepatic glucocorticoid response to mirex treatment.
    Brown LD; Wilson DE; Yarbrough JD
    Toxicol Appl Pharmacol; 1988 Feb; 92(2):203-13. PubMed ID: 2893471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
    Sun YN; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
    J Pharmacokinet Biopharm; 1998 Dec; 26(6):619-48. PubMed ID: 10485078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
    Nichols AI; D'Ambrosio R; Pyszczynski NA; Jusko WJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):963-70. PubMed ID: 2778721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indomethacin on the pharmacokinetics and pharmacodynamics of prednisolone in rats.
    Garg V; Jusko WJ
    J Pharm Sci; 1994 May; 83(5):747-50. PubMed ID: 7915309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
    Sun YN; DuBois DC; Almon RR; Jusko WJ
    J Pharmacokinet Biopharm; 1998 Jun; 26(3):289-317. PubMed ID: 10098101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.
    Xu ZX; Sun YN; DuBois DC; Almon RR; Jusko WJ
    J Pharmacokinet Biopharm; 1995 Apr; 23(2):163-81. PubMed ID: 8719235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of glucocorticoid receptor and induction of tyrosine aminotransferase in rat liver.
    Izawa M; Yoshida A; Ichii S
    Endocrinol Jpn; 1982 Apr; 29(2):209-18. PubMed ID: 6127207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glucocorticoid receptors during adaptive liver growth.
    Thottassery JV; Yarbrough JD
    Am J Physiol; 1991 Apr; 260(4 Pt 1):G603-9. PubMed ID: 1673321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent pharmacokinetics of prednisolone in normal and adrenalectomized rats.
    Boudinot FD; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Oct; 14(5):453-67. PubMed ID: 3806371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid regulation of hepatic cytosolic glucocorticoid receptors in vivo and its relationship to induction of tyrosine aminotransferase.
    Shirwany TA; Hubbard JR; Kalimi M
    Biochim Biophys Acta; 1986 Apr; 886(1):162-8. PubMed ID: 2869788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the dynamics of nuclear glucocorticoid-receptor complex: adding flexibility to gene expression modeling.
    Hazra A; DuBois DC; Almon RR; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):333-54. PubMed ID: 17285360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duration of antagonizing effect of RU486 on the agonist induction of tyrosine aminotransferase via glucocorticoid receptor.
    Alexandrová M
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):723-5. PubMed ID: 1348626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor dynamics and tyrosine aminotransferase induction during the course of chronic treatment of rats with glucocorticoid.
    Yoshida A; Noguchi T; Taniguchi S; Mitani Y; Ueda M; Urabe K; Adachi T; Okamura Y; Shigemasa C; Abe K
    Endocrinol Jpn; 1986 Dec; 33(6):769-75. PubMed ID: 2884094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids.
    Hazra A; Pyszczynski N; DuBois DC; Almon RR; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):643-67. PubMed ID: 17593325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.
    Ramakrishnan R; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2002 Feb; 29(1):1-24. PubMed ID: 12194533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated QSPR--pharmacodynamic model of genomic effects of several corticosteroids.
    Mager DE; Pyszczynski NA; Jusko WJ
    J Pharm Sci; 2003 Apr; 92(4):881-9. PubMed ID: 12661073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.